Male sex and hyperlipidemia were linked to higher MVX scores in the clinical trial, while obesity and NT-proBNP were linked to lower and higher MVX scores, respectively, in the cohort (p <.05). This evidence concerns the gene NPPB and obesity due to melanocortin 4 receptor deficiency.